Posted By: NITRC Moderator - Nov 4, 2009
Tool/Resource: NITRC Community
 
The Healthcare Informatics Department at IBM Almaden Research Center is involved in cutting edge research in medical imaging (www.almaden.ibm.com/cs/projects/aalim/), healthcare IT, and public health. We are currently looking for a Post-Doctoral Researcher to assist us on a recently issued NIH grant on medical image annotation and segmentation. The position will involve research and development in state-of-the-art medical imaging research applications. Specifically, the candidate will work in a small R&D team to create simple to use UIs for latest segmentation and annotation tools in 3D Slicer (www.slicer.org).

Major Duties/Responsibilities

- Develop comprehensive framework for annotation and markup of medical images
- Build platform for clinical researchers to tune automatic segmenters to their environment
- Create schemas for saving and recovering annotations into and from central data base
- Participate in dissemination activities
- Collaborate with all members of the research team
- Publish research reports at scientific journals

Qualifications

The successful candidate must have PhD in computer science or related field. The candidate is required to have practical experience in designing user interfaces as well as developing software in the medical image domain. Expertise in programming in C++ is required. Programming experience with Qt, VTK, ITK, and 3D Slicer on cross platforms environment is plus. Ability and willingness to work in a multidisciplinary team is a must.

How to Apply

Please submit CV and cover letter via https://jobs3.netmedia1.com/cp/job_summa...

IBM is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status.
RSS Feed Monitor in Slack
Latest News

This news item currently has no comments.